C-Reactive Protein and Risk of ESRD: Results From the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)

Finnian R. Mc Causland; Brian Claggett; Emmanuel A. Burdmann; Kai‐Uwe Eckardt; Reshma Kewalramani; Andrew S. Levey; John J.V. McMurray; Patrick S. Parfrey; Giuseppe Remuzzi; Ajay Singh; Scott D. Solomon; Robert D. Toto; Marc A. Pfeffer

doi:10.1053/j.ajkd.2016.07.022

Related publications

Article2009

Baseline Characteristics in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)

Marc A. Pfeffer, Emmanuel A. Burdmann, Chao-Yin Chen, Mark E. Cooper, Dick de Zeeuw, Kai‐Uwe Eckardt, Peter Ivanovich, Reshma Kewalramani, Andrew S. Levey, Eldrin F. Lewis, Janet B. McGill, John J.V. McMurray, Patrick S. Parfrey, Hans‐Henrik Parving, Giuseppe Remuzzi, Ajay Singh, Scott D. Solomon, Robert D. Toto, Hajime Uno

Article2005

Rationale—Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT): Evolving the management of cardiovascular risk in patients with chronic kidney disease

T.-Christian H. Mix, Robert Brenner, Mark E. Cooper, Dick de Zeeuw, Peter Ivanovich, Andrew S. Levey, Janet B. McGill, John J.V. McMurray, Patrick S. Parfrey, Hans‐Henrik Parving, Brian J.G. Pereira, Giuseppe Remuzzi, Ajay Singh, Scott D. Solomon, Catherine Stehman‐Breen, Robert D. Toto, Marc A. Pfeffer

Article2018

Treatment of Anemia With Darbepoetin Prior to Dialysis Initiation and Clinical Outcomes: Analyses From the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)

Finnian R. Mc Causland, Brian Claggett, Emmanuel A. Burdmann, Glenn M. Chertow, Mark E. Cooper, Kai‐Uwe Eckardt, Peter Ivanovich, Andrew S. Levey, Eldrin F. Lewis, Janet B. McGill, John J.V. McMurray, Patrick S. Parfrey, Hans‐Henrik Parving, Giuseppe Remuzzi, Ajay Singh, Scott D. Solomon, Robert D. Toto, Marc A. Pfeffer

Article2012

Hemoglobin Stability in Patients With Anemia, CKD, and Type 2 Diabetes: An Analysis of the TREAT (Trial to Reduce Cardiovascular Events With Aranesp Therapy) Placebo Arm

Hicham Skali, Julie Lin, Marc A. Pfeffer, Chao-Yin Chen, Mark E. Cooper, John J.V. McMurray, Allen R. Nissenson, Giuseppe Remuzzi, Jérôme Rossert, Patrick S. Parfrey, Nairne Scott‐Douglas, Ajay Singh, Robert D. Toto, Hajime Uno, Peter Ivanovich

Article2017

Change in Hemoglobin Trajectory and Darbepoetin Dose Approaching End-Stage Renal Disease: Data from the Trial to Reduce Cardiovascular Events with Aranesp Therapy Trial

Finnian R. Mc Causland, Brian Claggett, Marc A. Pfeffer, Emmanuel A. Burdmann, Kai‐Uwe Eckardt, Andrew S. Levey, John J.V. McMurray, Giuseppe Remuzzi, Ajay Singh, Scott D. Solomon, Robert D. Toto, Patrick S. Parfrey